Ligand Agrees to Acquire Core Assets, Partnered Programs and Ion Channel Technologies from Icagen February 11, 2020
Two Ligand Pharmaceuticals Board Members Recognized as 2019 Most Influential Corporate Directors by WomenInc. Magazine December 23, 2019
Ligand Presents Positive Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol November 8, 2019
Ligand to Participate in the H. C. Wainwright 21st Annual Global Investment Conference August 29, 2019